Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion type Assertion NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_head.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_provenance.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion evidence source_evidence_literature NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_provenance.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion SIO_000772 12684693 NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_provenance.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion wasDerivedFrom befree-20140225 NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_provenance.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion wasGeneratedBy ECO_0000203 NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_provenance.